Empagliflozin in Heart Failure with Reduced Ejection Fraction and End Stage Renal Disease
Clinical trial NCT06249932 · RECRUITING
Trial details
- NCT number
- NCT06249932
- Sponsor
- National Taiwan University Hospital
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-13
- Primary completion
- 2027-12-31
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.